$6.75
0.182.74%
Pre-Market: 5:09 AM EDT
Atara Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Atara Biotherapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-2.93 | $-1.93 | -51.8 % |
Q2 | 2024-08-12 | $-3.10 | $-1.56 | -98.7 % |
Q1 | 2024-05-09 | $-5.75 | $-6.50 | 11.5 % |
Q4 | 2024-03-28 | $-14.00 | $-12.00 | -16.7 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $40.19M | $35.17M | 14.3 % |
Q2 | 2024-08-12 | $28.64M | $39.99M | -28.4 % |
Q1 | 2024-05-09 | $27.36M | $24.69M | 10.8 % |
Q4 | 2024-03-28 | $4.25M | $11.55M | -63.2 % |
Atara Biotherapeutics (ATRA) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-2.93, which missed the estimate of $-1.93.
The Actual Revenue was $40.2M, which beat the estimate of $35.2M.
Browse earnings estimates, EPS, and revenue on all stocks.